IL1β and TNF-α secretion by SPP1-positive macrophages has been described and attributed to progressing HNSCC[41], but the atlas highlights the presence of this IL1β-positive SPP1-negative population as a discrete population that may be involved in unique signaling pathways contributing to tumor progression and drug resistance. The gene discussed is IL1B; the disease is neoplasm.